Gastroenterology

Research output

Research output per year 1992 2021

• 190 Article
• 52 Review Article
• 43 Letter
• 18 Editorial
• 17 More
  • 7 Chapter (Book)
  • 7 Comment / Debate
  • 1 Commissioned Report
  • 1 Meeting Abstract
  • 1 Short Survey

Research output per year

Research output per year

Search results

• 2021

  Dynamics of liver stiffness in chronic hepatitis B patients with concurrent metabolic-associated fatty liver disease

  Con, D., Clayton-Chubb, D., Lubel, J., Sawhney, R. & Bloom, S., 1 Jul 2021, In: Journal of Hepatology. 75, 1, p. 236-238 3 p.

  Research output: Contribution to journal › Letter › Other › peer-review

• Lessons From COVID-19, ACE2, and Intestinal Inflammation: Could a Virus Trigger Chronic Intestinal Inflammation?

  Hanrahan, T. P., Lubel, J. S. & Garg, M., Jan 2021, In: Clinical Gastroenterology and Hepatology. 19, 1, p. 206 1 p.

  Research output: Contribution to journal › Letter › Other › peer-review

  Open Access
  2 Citations (Scopus)
• 2020

  Embolisation of Parastomal Varices Using Balloon-Occluded Retrograde Transvenous Obliteration (BRTO)

  Clements, W., Roberts, S. K. & Moriarty, H. K., Aug 2020, In: CardioVascular and Interventional Radiology. 43, 8, p. 1246-1248 3 p.

  Research output: Contribution to journal › Letter › Other › peer-review
  1 Citation (Scopus)

• Gastrointestinal ACE2, COVID-19 and IBD: Opportunity in the Face of Tragedy?

  Garg, M., Christensen, B. & Lubel, J. S., Oct 2020, In: Gastroenterology. 159, 4, p. 1623-1624 2 p.

  Research output: Contribution to journal › Letter › Other › peer-review

  Open Access

  File
  6 Citations (Scopus)

• In support of community-based hepatitis C treatment with triage of people at risk of cirrhosis to specialist care

  Wade, A. J., Doyle, J. S., Draper, B., Howell, J., Iser, D., Roberts, S. K., Kemp, W., Thompson, A. J. & Hellard, M. E., 29 Aug 2020, (Accepted/In press) In: Journal of Viral Hepatitis. 2 p.

  Research output: Contribution to journal › Letter › Other › peer-review

• Letter: intestinal inflammation, COVID-19 and gastrointestinal ACE2 - exploring RAS inhibitors

  Garg, M., Royce, S. G. & Lubel, J. S., 6 May 2020, (Accepted/In press) In: Alimentary Pharmacology & Therapeutics. 2 p.

  Research output: Contribution to journal › Letter › Other › peer-review

  Open Access

  File
  5 Citations (Scopus)

• Letter: ACE2, IBD and COVID-19—why IBD patients may be at reduced risk of COVID-19

  Prentice, R. E., Tjandra, D., Garg, M., Lubel, J. S., Fourlanos, S., Johnson, D., Al-Ani, A. & Christensen, B., 1 Oct 2020, In: Alimentary Pharmacology and Therapeutics. 52, 8, p. 1422-1423 2 p.

  Research output: Contribution to journal › Letter › Other › peer-review

• Renin–angiotensin–aldosterone system inhibitors in CoviD-19

  Lubel, J. & Garg, M., 11 Jun 2020, In: New England Journal of Medicine. 382, 24, 3 p., e92.

  Research output: Contribution to journal › Letter › Other › peer-review
  6 Citations (Scopus)

• Survival of patients with ruptured and non-ruptured hepatocellular carcinoma

  Tan, N. P., Majeed, A., Roberts, S. K., Gow, P. J., Hey, P., Mah, X., Goodwin, M., Sood, S., Lubel, J., Nicoll, A., Dev, A., Bell, S. J. & Kemp, W. W., Apr 2020, In: Medical Journal of Australia. 212, 6, p. 277-278 2 p.

  Research output: Contribution to journal › Letter › Other › peer-review

  Open Access

  File

• The Importance of Accurate Phenotyping and Pouchitis Risk and Dietary Assessment When Investigating the Microbial Factors Behind Antibiotic-Dependent Pouchitis

  Ardalan, Z. S., Sparrow, M. & Gibson, P. R., 1 Jul 2020, In: Gastroenterology. 159, 1, p. 359-400 2 p.

  Research output: Contribution to journal › Letter › Other › peer-review

  Open Access
  1 Citation (Scopus)
• 2019

  Dietary fat and the faecal microbiome: Where collinearity may lead to incorrect attribution of effects to fat

  Ardalan, Z. S., Sparrow, M. P., Muir, J. G. & Gibson, P. R., Sep 2019, (Accepted/In press) In: Gut. 1 p.

  Research output: Contribution to journal › Letter › Other › peer-review
  2 Citations (Scopus)

• Efficacy of glutamine in postinfection IBS

  Ford, A. C. & Gibson, P. R., 1 Oct 2019, In: Gut. 68, 10, p. 1905-1906 2 p.

  Research output: Contribution to journal › Letter › Other › peer-review

• Letters: low FODMAP diet-directions for future research and the low FODMAP diet is not the only diet for IBS-authors' reply

  Mitchell, H., Porter, J., Gibson, P. R., Barrett, J. & Garg, M., 1 Apr 2019, In: Alimentary Pharmacology & Therapeutics. 49, 8, p. 1109-1110 2 p.

  Research output: Contribution to journal › Letter › Other › peer-review

  Open Access

• Prebiotics Versus Low FODMAP Diet: An Interpretative Nightmare

  Varney, J., Muir, J. G. & Gibson, P. R., Mar 2019, In: Gastroenterology. 156, 4, p. 1222 1 p.

  Research output: Contribution to journal › Letter › Other › peer-review

  Open Access
  1 Citation (Scopus)

• Reply

  Colombel, J. F., Shin, A. & Gibson, P. R., Feb 2019, In: Clinical Gastroenterology and Hepatology. 17, 3, p. 573-574 2 p.

  Research output: Contribution to journal › Letter › Other › peer-review

  Open Access
• 2018

  Is Non-Celiac Rice-Starch Sensitivity as Common in Children as Non-Celiac Gluten Sensitivity?

  Gibson, P. R., Lundin, K. E. A. & Guandalini, S., 1 Aug 2018, In: The American Journal of Gastroenterology. 113, 8, 1 p.

  Research output: Contribution to journal › Letter › Other › peer-review
  4 Citations (Scopus)

• Letter: vedolizumab drug concentrations in neonates following intrauterine exposure

  Flanagan, E., Gibson, P. R., Begun, J., Ghaly, S., Garg, M., Andrews, J. M., Rosella, O., Rosella, G. & Bell, S. J., 1 Dec 2018, In: Alimentary Pharmacology & Therapeutics. 48, 11-12, p. 1328-1330 3 p.

  Research output: Contribution to journal › Letter › Other › peer-review
  9 Citations (Scopus)

• Letter: vedolizumab for autoimmune liver disease associated inflammatory bowel disease—Authors’ reply

  Christensen, B., Gibson, P. R. & Rubin, D. T., May 2018, In: Alimentary Pharmacology & Therapeutics. 47, 10, p. 1423-1424 2 p.

  Research output: Contribution to journal › Letter › Other › peer-review

  Open Access
  3 Citations (Scopus)

• Reply

  Skodje, G. I., Henriksen, C., Veierød, M. B., Gibson, P. R. & Lundin, K. E. A., Jul 2018, In: Gastroenterology. 155, 1, 1 p.

  Research output: Contribution to journal › Letter › Other › peer-review
  1 Citation (Scopus)
• 2017

  Letter: low-FODMAP diet for exercise-induced gastrointestinal syndrome—Authors’ reply

  Da Costa, R. J., Snipe, R. M. J., Kitic, C. & Gibson, P. R., 1 Nov 2017, In: Alimentary Pharmacology & Therapeutics. 46, 10, p. 1023-1024 2 p.

  Research output: Contribution to journal › Letter › Other › peer-review

  Open Access
  4 Citations (Scopus)

• Letter: bias in clinical trials of the symptomatic effects of the low FODMAP diet for irritable bowel syndrome—getting the facts right

  Gibson, P. R., Halmos, E. P. & Muir, J. G., 1 Aug 2017, In: Alimentary Pharmacology & Therapeutics. 46, 3, p. 385-386 2 p.

  Research output: Contribution to journal › Letter › Other › peer-review
  3 Citations (Scopus)

• New onset vitiligo following commencement of infliximab in Crohn disease

  Luber, R. P., Chamberlain, A. J. & Sparrow, M. P., 1 Aug 2017, In: Internal Medicine Journal. 47, 8, p. 972-973 2 p.

  Research output: Contribution to journal › Letter › Other › peer-review
  2 Citations (Scopus)

• Train-the-trainer education and colonoscopy quality indicators: Where to now?

  Roberts, S. K., 1 Aug 2017, In: Gut. 66, 8, p. 1533-1534 2 p.

  Research output: Contribution to journal › Letter › Other › peer-review
• 2016

  Diet Therapy for Irritable Bowel Syndrome: Is a Diet Low in FODMAPS Really Similar in Efficacy to Traditional Dietary Advice?

  Gibson, P. R., Varney, J. E. & Muir, J. G., 1 Apr 2016, In: Gastroenterology. 150, 4, p. 1046-1047 2 p.

  Research output: Contribution to journal › Letter › Other › peer-review
  4 Citations (Scopus)

• Supersonic Shear Imaging and Transient Elastography in Obesity

  Thwaites, P. A., Roberts, S. K., Kitson, M. & Kemp, W., 1 Mar 2016, In: Clinical Gastroenterology and Hepatology. 14, 3, p. 484 1 p.

  Research output: Contribution to journal › Letter › Other › peer-review
  1 Citation (Scopus)
• 2015

  Association between reduced plasma 25-hydroxyvitamin D and increased risk of cancer in patients with inflammatory bowel disease

  Kitson, M. T., Garg, M. & Roberts, S. K., 1 Apr 2015, In: Clinical Gastroenterology and Hepatology. 13, 4, p. 813-814 2 p.

  Research output: Contribution to journal › Letter › Other › peer-review
  1 Citation (Scopus)

• Editorial: a new shift in the paradigm of treatment for the irritable bowel syndrome?

  Peters, S. L. & Gibson, P. R., 2015, In: Alimentary Pharmacology & Therapeutics. 41, 12, p. 1296 - 1296 1 p.

  Research output: Contribution to journal › Letter › Other

• Relationship between vitamin D status and response to hepatitis C virus therapy

  Kitson, M. T., Sarrazin, C., Toniutto, P. & Roberts, S. K., 1 Nov 2015, In: Hepatology. 62, 5, p. 1642-1643 2 p.

  Research output: Contribution to journal › Letter › Other › peer-review
  2 Citations (Scopus)

• Reply to: "evidence supporting a beneficial role of Vitamin D in chronic hepatitis C"

  Kitson, M. T., Sarrazin, C., Toniutto, P. & Roberts, S. K., 2015, In: Journal of Hepatology. 63, 2, p. 531-532 2 p.

  Research output: Contribution to journal › Letter › Other › peer-review
• 2014

  Editorial: Noncoeliac gluten sensitivity - A disease of the mind or gut? Authors' reply

  Peters, S. L., Biesiekierski, J. R., Yelland, G. W., Muir, J. G. & Gibson, P. R., 2014, In: Alimentary Pharmacology & Therapeutics. 40, 1, p. 114-115 2 p.

  Research output: Contribution to journal › Letter › Other › peer-review
  1 Citation (Scopus)

• Editorial: `Brain Fog' and coeliac disease - evidence for its existence: authors' reply

  Lichtwark, I. T., Newnham, E., Robinson, S. R., Gibson, P. R. & Yelland, G. W., 2014, In: Alimentary Pharmacology & Therapeutics. 40, 5, p. 566 - 566 1 p.

  Research output: Contribution to journal › Letter › Other

• Open source clinical science for emerging infections

  Dunning, J. W., Merson, L., Rohde, G. G. U., Gao, Z., Semple, M. G., Tran, D., Gordon, A., Olliaro, P. L., Khoo, S. H., Bruzzone, R., Horby, P., Cobb, J. P., Longuere, K. S., Kellam, P., Nichol, A., Brett, S., Everett, D. B., Walsh, T. S., Hien, T. T. M., Yu, H. & 14 others, Zambon, M., Ruiz-Palacios, G., Lang, T., Akhvlediani, T., Hayden, F. G., Marshall, J., Webb, S., Angus, D. C., Shindo, N., van der Werf, S., Openshaw, P. J. M., Farrar, J., Carson, G. & Baillie, J. K., Jan 2014, In: Lancet Infectious Diseases. 14, 1, p. 8-9 2 p.

  Research output: Contribution to journal › Letter › Other › peer-review
  28 Citations (Scopus)

• Reply

  Halmos, E. P., Muir, J. G. & Gibson, P. R., 2014, In: Gastroenterology. 146, 7, p. 1830-1831 2 p.

  Research output: Contribution to journal › Letter › Other › peer-review
  3 Citations (Scopus)
• 2013

  Commentary: Sugar intolerances in functional gastrointestinal disorders

  Barrett, J. S. & Gibson, P. R., 2013, In: Alimentary Pharmacology & Therapeutics. 38, 1, p. 72 - 72 1 p.

  Research output: Contribution to journal › Letter › Other
  1 Citation (Scopus)

• Not all effects of a gluten-free diet are due to removal of gluten

  Gibson, P. R. & Muir, J. G., 2013, In: Gastroenterology. 145, 3, p. 693 - 693 1 p.

  Research output: Contribution to journal › Letter › Other
  17 Citations (Scopus)

• Pathogenesis of colonic diverticulosis: repainting the picture

  Burgell, R., Muir, J. G. & Gibson, P. R., 2013, In: Clinical Gastroenterology and Hepatology. 11, 12, p. 1628 - 1630 3 p.

  Research output: Contribution to journal › Letter › Other
  7 Citations (Scopus)

• Reply to: "vitamin D status does not predict sustained virologic response or fibrosis stage in chronic hepatitis C genotype 1 infection"

  Kitson, M. T., Button, P. & Roberts, S. K., Jul 2013, In: Journal of Hepatology. 59, 1, p. 194-195 2 p.

  Research output: Contribution to journal › Letter › Other › peer-review

  Open Access

  File
  2 Citations (Scopus)

• The low FODMAP diet for treatment of irritable bowel syndrome and other gastrointestinal disorders

  Muir, J. G. & Gibson, P. R., 2013, In: Gastroenterology and Hepatology. 9, 7, p. 450 - 452 3 p.

  Research output: Contribution to journal › Letter › Other

  28 Citations (Scopus)
• 2012

  Feasibility and performance of the FibroScan XL probe

  Kemp, W. & Roberts, S., Apr 2012, In: Hepatology. 55, 4, p. 1308-1309 2 p.

  Research output: Contribution to journal › Letter › Other › peer-review
  5 Citations (Scopus)

• Why thiopurine metabolites are relevant

  Friedman, A. B., Sparrow, M. P. & Gibson, P. R., Feb 2012, In: Alimentary Pharmacology & Therapeutics. 35, 3, p. 400-401 2 p.

  Research output: Contribution to journal › Letter › Other › peer-review
  2 Citations (Scopus)
• 2011

  Reply

  Sievert, W., Dore, G. J. & Roberts, S. K., May 2011, In: Hepatology. 53, 5, p. 1775-1776 2 p.

  Research output: Contribution to journal › Letter › Other › peer-review

• Response to Clarke K, Regueiro M. Stopping immunomodulators and biologics in inflammatory bowel disease patients in remission. Inflamm Bowel Dis 2011 [Epub ahead of print].

  Friedman, A. B. & Sparrow, M. P., Dec 2011, In: Inflammatory Bowel Diseases. 17, 12

  Research output: Contribution to journal › Letter › Other › peer-review
  1 Citation (Scopus)
• 2009

  Author response

  Barrett, J. S., Shepherd, S. J. & Gibson, P. R., Nov 2009, In: Journal of Parenteral and Enteral Nutrition. 33, 6, p. 733-734 2 p.

  Research output: Contribution to journal › Letter › Other › peer-review